MENTEN AI
Menten AI designs new protein drugs and enzymes using quantum computers and machine learning. Proteins are large molecules that can twist into many shapes. Discovering the right shape for a protein to be a drug or a biocatalyst among almost endless possibilities is a major challenge. Menten AI solves this problem by using machine learning and quantum computing to find better starting points for discovery and further development. Quantum computing makes it possible to represent multiple states of the protein simultaneously and efficiently find the best designs. The team created the world’s first peptide designed on a quantum computer and is now working on peptide therapeutics for oncology and neurodegeneration, as well as on enzymes for industrial applications.
MENTEN AI
Industry:
Artificial Intelligence Biotechnology Chemical Health Care Life Science Machine Learning Pharmaceutical Quantum Computing Therapeutics
Founded:
2018-08-24
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.menten.ai
Total Employee:
1+
Status:
Active
Total Funding:
4.01 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag Euro
Similar Organizations
AQEMIA
Drug discovery - Pharma 3.0
Athos Therapeutics
Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
Atomwise
Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
Bactana Corp.
Bactana develops therapies for pets to treat prediabetes, diabetes and products to reduce antibiotic use during livestock production.
BridgeBio Pharma
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
CytoVale
Categorized is a medical technology company that revolutionizes diagnostics using cell mechanics and machine learning.
DIG Labs
Unleashing the power of visual data to supercharge brand experiences and closely connect companies to their consumers.
Engine Biosciences
Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.
Envisagenics
Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.
Flaskworks
Flaskworks is improves the manufacture of immuno-therapeutics and dendritic cell-based vaccines.
HealthMode
HealthMode delivers AI-enabled digital measurement methods to increase the precision and speed of clinical research, and improve healthcare.
Nines
Nines is the first-of-its-kind radiology practice. Radiologists + Data Scientists + Engineers. Trusted partner.
Osmol Therapeutics
Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy.
Pharmacelera
Quantum-Mechanics (QM) and Machine Learning (ML) Drug Discovery
Testmate Health
Testmate Health builds self-testing kits that allow you you skip the waiting room & get results at home in minutes.
Scioto Biosciences
Scioto is a developer of Activated Bacterial Therapeutics platform.
Current Advisors List
Board_observer
Current Employees Featured
Hans Melo Co-Founder and CEO @ Menten AI
Co-Founder and CEO
Tamas Gorbe Co-Founder and COO @ Menten AI
Co-Founder and COO
Helen Liang Investor @ Menten AI
Investor
2020-03-01
Vikram K. Mulligan Academic Co-Founder @ Menten AI
Academic Co-Founder
Founder
Investors List
Social Impact Capital
Social Impact Capital investment in Seed Round - Menten AI
FoundersX Ventures
FoundersX Ventures investment in Seed Round - Menten AI
Khosla Ventures
Khosla Ventures investment in Seed Round - Menten AI
Uncork Capital
Uncork Capital investment in Seed Round - Menten AI
Y Combinator
Y Combinator investment in Pre Seed Round - Menten AI
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Pre Seed Round - Menten AI
Official Site Inspections
http://www.menten.ai Semrush global rank: 5.74 M Semrush visits lastest month: 1.46 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Menten AI"
Menten AI - Crunchbase Company Profile & Funding
Menten AI designs new protein drugs and enzymes using quantum computers and machine learning. Proteins are large molecules that can twist into many …See details»
Team | Menten AI
Humans of Menten AI. At Menten AI, we’re on a mission to create the next generation of protein-based drugs using machine learning. We’re an early-stage drug discovery company …See details»
Menten AI - LinkedIn
Menten AI | 5,045 followers on LinkedIn. Building the world's most advanced generative AI platform for peptide therapeutics design. | Menten AI is a drug discovery company focused on designing ...See details»
Menten AI 2025 Company Profile: Valuation, Funding …
Menten AI has raised $4.36M. Who are Menten AI’s investors? Feld Ventures , Mana Ventures , Quain Investments , Society Health , and Volpini Ventures …See details»
Menten AI - Funding, Financials, Valuation & Investors - Crunchbase
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How …See details»
Menten - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 25, 2025 Menten is a seed company based in Toronto (Canada), founded in 2018 by Tamas Gorbe, Vikram Mulligan and Hans Melo. It operates as a Developer of peptides using AI …See details»
Menten AI - Org Chart, Teams, Culture & Jobs - The Org
Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical needs. They develop computational methods for protein design that leverage …See details»
University of Toronto Entrepreneurship | Menten AI
Menten AI produces custom enzymes by reverse-engineering a desired chemical reaction and designing enzymes that catalyze the reaction. Currently, the development of new enzymes involves a complex process that is …See details»
Menten AI Inc - Company Profile and News - Bloomberg Markets
Company profile page for Menten AI Inc including stock price, company news, executives, board members, and contact informationSee details»
Menten AI - Contacts, Employees, Board Members, Advisors
Organization. Menten AI . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
Newsroom | Menten AI
Menten AI's CEO, Dr. Hans Melo, will be sharing the latest developments at Menten AI in Boulder on adding drug-like properties including plasma stability and membrane-permeability. March …See details»
Menten AI - eqtfoundation.com
Menten AI, a pioneering company in the field of generative AI for drug design, is making significant strides in the pharmaceutical industry. Supported by leading venture capital firms …See details»
Menten AI - Company info. interviews, news
Menten is a biotech startup developing a software platform for protein design empowered by machine learning and quantum computing. Menten’s quantum approach aims to overcome the …See details»
Menten AI | News, Hiring, Layoffs, Competitors, CEO, Fundraising …
Apr 25, 2025 Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. The company is developing the world's most …See details»
Menten AI | Startup Profile and Investments - Bounce Watch
Menten AI is a drug discovery company founded in 2018 with the mission of designing peptides for conditions with high unmet medical need. Their slogan, "Building the world's most …See details»
Menten AI: Revenue, Worth, Valuation & Competitors 2025
About Menten AI. Menten AI is an Artificial Intelligence (AI) related company founded in 2018 and based in San Francisco with 15 employees an estimated revenue of $1.3M, and. It has 10 …See details»
Menten AI - Craft
Menten AI is a drug discovery company that develops a generative AI platform for peptide therapeutics. Its platform uses physics-based design and machine learning to simulate and …See details»
Menten AI Company Information - Funding, Investors, and More
Menten AI. A company using quantum computing and machine learning to design proteins. Seedtable Score 76 Startups. 3. Funding Rounds. $8.1m. Money raised. About; Insights; …See details»
OpenAI will continue to be controlled by nonprofit amid …
10 hours ago OpenAI announced Monday it has updated its restructuring plan to allow its nonprofit to retain control of the for-profit arm of the unorthodox technology organization, amid …See details»
OpenAI nonprofit will retain control of the AI company | Mashable
6 hours ago The nonprofit status of OpenAI is one of the biggest controversies in Silicon Valley. On Monday, May 5, CEO Sam Altman said the company structure is "evolving."See details»